AnaptysBio, Inc. (ANAB)
44.99
+1.19
(+2.72%)
USD |
NASDAQ |
Dec 10, 15:29
AnaptysBio Total Liabilities (Quarterly): 382.51M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 19.15M |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| CorMedix, Inc. | 376.73M |
| Verastem, Inc. | 192.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 353.10M |
| Shareholders Equity (Quarterly) | -29.42M |
| Debt to Equity Ratio | -11.78 |
| Current Ratio | 8.678 |
| Net Debt Paydown Yield | 0.77% |